Skip to main content
. 2017 Mar 28;2017(3):CD011343. doi: 10.1002/14651858.CD011343.pub2

1.3. Analysis.

1.3

Comparison 1 Pharmacological treatments for primary sclerosing cholangitis: not stratified by ursodeoxycholic acid dose, Outcome 3 Serious adverse events number.